Gonadotropin-releasing hormone antagonists in controlled ovarian stimulation

被引：0

作者：

Diedrich, Klaus ^{[1
]}

Felberbaum, Ricardo ^{[2
]}

Al-Hasani, Safaa ^{[1
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde, Ratzeburger Allee 160, D-23538 Lubeck, Germany

[2] Klin Verbund Allgau, Klin Gynakol & Geburtshilfe Kempten & Immenstadt, Kempten, Germany

来源：

GYNAKOLOGE | 2020年 / 53卷 / 08期

关键词：

Ovarian hyperstimulation syndrome; Ovulation induction; Pregnancy rate; Reproductive techniques; assisted; Progesterone; INVITRO FERTILIZATION; CETRORELIX;

D O I：

10.1007/s00129-020-04634-y

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian stimulation is one of the most important stages in assisted reproduction. The first attempts at stimulation with gonadotropins and gonadotropin-releasing hormone (GnRH) agonists were costly and relatively unsuccessful with many cases of overstimulation. Only the introduction of GnRH antagonists resulted in important progress. The advantages are a shorter duration of treatment and a simplified treatment with less side effects (overstimulation syndrome). In addition, the live birth rate is comparable with that of earlier antagonist protocols. Novel stimulation protocols could be developed with the important possibility to avoid overstimulation (oocyte freezing). In Germany and Europe approximately 70% of the patients are stimulated with the gonadotropins/antagonists protocol.

引用

页码：517 / 521

页数：5

共 50 条

[1] Gonadotropin-releasing hormone antagonists: A first line ovarian stimulation protocol for IVF?
Conway, D. A.
Talebian, S.
Noyes, N.
Krey, L. C.
Grifo, J. A.
[J]. FERTILITY AND STERILITY, 2006, 86 : S440 - S440
[2] The role of gonadotropin-releasing hormone antagonists in ovarian stimulation-still a controversy?
Griesinger, Georg
[J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2020, 18 (02): : 108 - 112
[3] Gonadotropin-releasing hormone antagonists
Herbst, KL
[J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) : 660 - 666
[4] The use of gonadotropin-releasing hormone antagonist in ovarian stimulation
Olivennes, F
[J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2006, 49 (01): : 12 - 22
[5] Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer
Kittai, Adam S.
Blank, Jessica
Graff, Julie N.
[J]. ONCOLOGY-NEW YORK, 2018, 32 (12): : 599 - 606
[6] Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix
Bahceci, M
Ulug, U
Tosun, S
Erden, HF
Bayazit, N
[J]. FERTILITY AND STERILITY, 2006, 85 (05) : 1523 - 1525
[7] Gonadotropin-Releasing Hormone Antagonists Revolutionizing Gynecology
Esencan, Ecem
Taylor, Hugh S.
[J]. OBSTETRICS AND GYNECOLOGY, 2022, 140 (06): : 917 - 919
[8] Defining the best protocol of controlled ovarian hyperstimulation for intrauterine insemination: A role for gonadotropin-releasing hormone antagonists?
Somigliana, E.
Crosignani, P. G.
[J]. FERTILITY AND STERILITY, 2006, 86 : S406 - S406
[9] THE FREQUENCY OF GONADOTROPIN-RELEASING HORMONE STIMULATION DETERMINES THE NUMBER OF PITUITARY GONADOTROPIN-RELEASING HORMONE RECEPTORS
KATT, JA
DUNCAN, JA
HERBON, L
BARKAN, A
MARSHALL, JC
[J]. ENDOCRINOLOGY, 1985, 116 (05) : 2113 - 2115
[10] RELATIVE POTENCIES OF GONADOTROPIN-RELEASING HORMONE AGONISTS AND ANTAGONISTS ON OVARIAN AND PITUITARY FUNCTIONS
HSUEH, AJW
ADASHI, EY
TUCKER, E
VALK, C
LING, NC
[J]. ENDOCRINOLOGY, 1983, 112 (02) : 689 - 695

← 1 2 3 4 5 →